Publication | Open Access
A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults
34
Citations
6
References
2025
Year
These findings support the potential benefit of mRNA-1010 as a seasonal influenza vaccine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1